These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 7957209)

  • 1. Structural characterisation of human stefin A in solution and implications for binding to cysteine proteinases.
    Martin JR; Jerala R; Kroon-Zitko L; Zerovnik E; Turk V; Waltho JP
    Eur J Biochem; 1994 Nov; 225(3):1181-94. PubMed ID: 7957209
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The three-dimensional solution structure of human stefin A.
    Martin JR; Craven CJ; Jerala R; Kroon-Zitko L; Zerovnik E; Turk V; Waltho JP
    J Mol Biol; 1995 Feb; 246(2):331-43. PubMed ID: 7869384
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Solution structure of a human cystatin A variant, cystatin A2-98 M65L, by NMR spectroscopy. A possible role of the interactions between the N- and C-termini to maintain the inhibitory active form of cystatin A.
    Tate S; Ushioda T; Utsunomiya-Tate N; Shibuya K; Ohyama Y; Nakano Y; Kaji H; Inagaki F; Samejima T; Kainosho M
    Biochemistry; 1995 Nov; 34(45):14637-48. PubMed ID: 7578072
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Importance of the second binding loop and the C-terminal end of cystatin B (stefin B) for inhibition of cysteine proteinases.
    Pol E; Björk I
    Biochemistry; 1999 Aug; 38(32):10519-26. PubMed ID: 10441148
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Grafting of features of cystatins C or B into the N-terminal region or second binding loop of cystatin A (stefin A) substantially enhances inhibition of cysteine proteinases.
    Pavlova A; Björk I
    Biochemistry; 2003 Sep; 42(38):11326-33. PubMed ID: 14503883
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Crystal structure of Stefin A in complex with cathepsin H: N-terminal residues of inhibitors can adapt to the active sites of endo- and exopeptidases.
    Jenko S; Dolenc I; Guncar G; Dobersek A; Podobnik M; Turk D
    J Mol Biol; 2003 Feb; 326(3):875-85. PubMed ID: 12581647
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differences in specificity for the interactions of stefins A, B and D with cysteine proteinases.
    Lenarcic B; Krizaj I; Zunec P; Turk V
    FEBS Lett; 1996 Oct; 395(2-3):113-8. PubMed ID: 8898076
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The refined 2.4 A X-ray crystal structure of recombinant human stefin B in complex with the cysteine proteinase papain: a novel type of proteinase inhibitor interaction.
    Stubbs MT; Laber B; Bode W; Huber R; Jerala R; Lenarcic B; Turk V
    EMBO J; 1990 Jun; 9(6):1939-47. PubMed ID: 2347312
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization by spectroscopic, kinetic and equilibrium methods of the interaction between recombinant human cystatin A (stefin A) and cysteine proteinases.
    Pol E; Olsson SL; Estrada S; Prasthofer TW; Björk I
    Biochem J; 1995 Oct; 311 ( Pt 1)(Pt 1):275-82. PubMed ID: 7575465
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular mechanism of inhibition of cysteine proteinases by their protein inhibitors: kinetic studies with natural and recombinant variants of cystatins and stefins.
    Machleidt W; Thiele U; Assfalg-Machleidt I; Förger D; Auerswald EA
    Biomed Biochim Acta; 1991; 50(4-6):613-20. PubMed ID: 1801731
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of Gly-4 of human cystatin A (stefin A) in the binding of target proteinases. Characterization by kinetic and equilibrium methods of the interactions of cystatin A Gly-4 mutants with papain, cathepsin B, and cathepsin L.
    Estrada S; Nycander M; Hill NJ; Craven CJ; Waltho JP; Björk I
    Biochemistry; 1998 May; 37(20):7551-60. PubMed ID: 9585570
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Major differences in stability and dimerization properties of two chimeric mutants of human stefins.
    Kenig M; Jerala R; Kroon-Zitko L; Turk V; Zerovnik E
    Proteins; 2001 Mar; 42(4):512-22. PubMed ID: 11170205
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contributions of individual residues in the N-terminal region of cystatin B (stefin B) to inhibition of cysteine proteinases.
    Pol E; Björk I
    Biochim Biophys Acta; 2003 Jan; 1645(1):105-12. PubMed ID: 12535617
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of the single cysteine residue, Cys 3, of human and bovine cystatin B (stefin B) in the inhibition of cysteine proteinases.
    Pol E; Björk I
    Protein Sci; 2001 Sep; 10(9):1729-38. PubMed ID: 11514663
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elongation on the amino-terminal part of stefin B decreases inhibition of cathepsin H.
    Jerala R; Kroon-Zitko L; Popovic T; Turk V
    Eur J Biochem; 1994 Sep; 224(3):797-802. PubMed ID: 7925405
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Probing the functional role of the N-terminal region of cystatins by equilibrium and kinetic studies of the binding of Gly-11 variants of recombinant human cystatin C to target proteinases.
    Björk I; Brieditis I; Abrahamson M
    Biochem J; 1995 Mar; 306 ( Pt 2)(Pt 2):513-8. PubMed ID: 7887904
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differences in the effects of TFE on the folding pathways of human stefins A and B.
    Zerovnik E; Virden R; Jerala R; Kroon-Zitko L; Turk V; Waltho JP
    Proteins; 1999 Aug; 36(2):205-16. PubMed ID: 10398367
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The importance of the second hairpin loop of cystatin C for proteinase binding. Characterization of the interaction of Trp-106 variants of the inhibitor with cysteine proteinases.
    Björk I; Brieditis I; Raub-Segall E; Pol E; Håkansson K; Abrahamson M
    Biochemistry; 1996 Aug; 35(33):10720-6. PubMed ID: 8718861
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The amino acid sequences, structure comparisons and inhibition kinetics of sheep cathepsin L and sheep stefin B.
    Ritonja A; Coetzer TH; Pike RN; Dennison C
    Comp Biochem Physiol B Biochem Mol Biol; 1996 Jun; 114(2):193-8. PubMed ID: 8759291
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deletion of the carboxy terminal part of stefin B does not have a major effect for binding to papain.
    Jerala R; Kroon-Zitko L; Kopitar M; Popovic T; Turk V
    Biomed Biochim Acta; 1991; 50(4-6):627-9. PubMed ID: 1801733
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.